Ida Unhammer Njerve, Sissel Åkra, Thomas W. Weiss, Svein Solheim, Reidun Øvstebø, Hans Christian D. Aass, . . . Ingebjørg Seljeflot. (2017). A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery Disease. Hindawi Limited.
Chicago Style (17th ed.) CitationIda Unhammer Njerve, Sissel Åkra, Thomas W. Weiss, Svein Solheim, Reidun Øvstebø, Hans Christian D. Aass, Rune Byrkjeland, Harald Arnesen, and Ingebjørg Seljeflot. A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin Versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery Disease. Hindawi Limited, 2017.
MLA (9th ed.) CitationIda Unhammer Njerve, et al. A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin Versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery Disease. Hindawi Limited, 2017.